Published in Acta Neurochir Suppl on January 01, 2008
Deferoxamine treatment for intracerebral hemorrhage in aged rats: therapeutic time window and optimal duration. Stroke (2009) 1.36
Elevated metals compromise repair of oxidative DNA damage via the base excision repair pathway: implications of pathologic iron overload in the brain on integrity of neuronal DNA. J Neurochem (2009) 0.93
Towards the prevention of potential aluminum toxic effects and an effective treatment for Alzheimer's disease. J Inorg Biochem (2011) 0.91
Combined therapy of iron chelator and antioxidant completely restores brain dysfunction induced by iron toxicity. PLoS One (2014) 0.84
Clinically available iron chelators induce neuroprotection in the 6-OHDA model of Parkinson's disease after peripheral administration. J Neural Transm (Vienna) (2010) 0.83
Heme oxygenase-2 modulates early pathogenesis after traumatic injury to the immature brain. Dev Neurosci (2010) 0.80
The ferric iron chelator 2,2'-dipyridyl attenuates basilar artery vasospasm and improves neurological function after subarachnoid hemorrhage in rabbits. Neurol Sci (2014) 0.78
Knockout of ho-1 protects the striatum from ferrous iron-induced injury in a male-specific manner in mice. Sci Rep (2016) 0.78
Solid microparticles based on chitosan or methyl-β-cyclodextrin: a first formulative approach to increase the nose-to-brain transport of deferoxamine mesylate. J Control Release (2015) 0.77
Brain iron overload following intracranial haemorrhage. Stroke Vasc Neurol (2016) 0.77
The Injury and Therapy of Reactive Oxygen Species in Intracerebral Hemorrhage Looking at Mitochondria. Oxid Med Cell Longev (2016) 0.75
Preclinical Studies and Translational Applications of Intracerebral Hemorrhage. Biomed Res Int (2017) 0.75
Skull x-ray examinations after head trauma. Recommendations by a multidisciplinary panel and validation study. N Engl J Med (1987) 4.07
Thrombin-soaked gelatin sponge and brain edema in rats. J Neurosurg (1996) 2.65
Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model. Neurosurgery (1992) 2.32
Role of blood clot formation on early edema development after experimental intracerebral hemorrhage. Stroke (1998) 2.25
Contaminants in the Canadian Arctic: 5 years of progress in understanding sources, occurrence and pathways. Sci Total Environ (2000) 2.16
The role of thrombin in gliomas. J Thromb Haemost (2005) 2.13
Magnetic resonance evaluation of ventrolateral medullary compression in essential hypertension. J Neurosurg (1998) 2.10
Acute inflammatory reaction following experimental intracerebral hemorrhage in rat. Brain Res (2000) 1.90
Erythrocytes and delayed brain edema formation following intracerebral hemorrhage in rats. J Neurosurg (1998) 1.81
Lobar intracerebral hemorrhage model in pigs: rapid edema development in perihematomal white matter. Stroke (1996) 1.79
Experimental intracerebral hemorrhage: relationship between brain edema, blood flow, and blood-brain barrier permeability in rats. J Neurosurg (1994) 1.78
Systemic complement depletion diminishes perihematomal brain edema in rats. Stroke (2001) 1.75
Neurovascular compression and essential hypertension. J Neurosurg (1992) 1.70
Decreased mortality from brain abscesses since advent of computerized tomography. J Neurosurg (1978) 1.61
Glossopharyngeal schwannoma: review of five cases and the literature. Surg Neurol (1991) 1.54
Efficacious experimental stroke treatment with high-dose methylprednisolone. Stroke (1994) 1.51
Attenuation of thrombin-induced brain edema by cerebral thrombin preconditioning. Stroke (1999) 1.49
Cerebral edema induced by arachidonic acid: role of leukocytes and 5-lipoxygenase products. Neurosurgery (1989) 1.42
Mechanisms of edema formation after intracerebral hemorrhage: effects of thrombin on cerebral blood flow, blood-brain barrier permeability, and cell survival in a rat model. J Neurosurg (1997) 1.42
Blood-brain barrier function in intracerebral hemorrhage. Acta Neurochir Suppl (2008) 1.31
Nonoperative treatment of brain abscesses in selected high-risk patients. J Neurosurg (1980) 1.30
Craniopharyngiomas in children and adults. J Neurosurg (1972) 1.27
Use of factor IX complex in warfarin-related intracranial hemorrhage. Neurosurgery (1999) 1.27
Mechanisms of edema formation after intracerebral hemorrhage: effects of extravasated red blood cells on blood flow and blood-brain barrier integrity. Stroke (2001) 1.26
Localization of regions mediating the Cushing response in CNS of cat. Arch Neurol (1970) 1.24
Brain edema and cerebrovascular permeability during cerebral ischemia in rats. Stroke (1990) 1.21
Brain fluid calcium concentration and response to acute hypercalcaemia during development in the rat. J Physiol (1988) 1.19
Hypoglycemic brain injury: potentiation from respiratory depression and injury aggravation from hyperglycemic treatment overshoots. J Cereb Blood Flow Metab (2000) 1.18
Attenuation of intracerebral hemorrhage and thrombin-induced brain edema by overexpression of interleukin-1 receptor antagonist. J Neurosurg (2001) 1.18
Ultra-early clot aspiration after lysis with tissue plasminogen activator in a porcine model of intracerebral hemorrhage: edema reduction and blood-brain barrier protection. J Neurosurg (1999) 1.18
Presentation of intracerebral haemorrhage in a community. J Neurol Neurosurg Psychiatry (2006) 1.16
Intracerebral hemorrhage-induced neuronal death. Neurosurgery (2001) 1.16
Seizures induced by intracerebral injection of thrombin: a model of intracerebral hemorrhage. J Neurosurg (1997) 1.14
Early metabolic alterations in edematous perihematomal brain regions following experimental intracerebral hemorrhage. J Neurosurg (1998) 1.13
Evaluation of the confidential unit exclusion form: the Canadian Blood Services experience. Vox Sang (2009) 1.12
Plasminogen activators potentiate thrombin-induced brain injury. Stroke (1998) 1.12
Edema from intracerebral hemorrhage: the role of thrombin. J Neurosurg (1996) 1.12
Contributions of ions and albumin to the formation and resolution of ischemic brain edema. J Neurosurg (1993) 1.11
The control of potassium concentration in the cerebrospinal fluid and brain interstitial fluid of developing rats. J Physiol (1987) 1.11
Inflammation and brain edema: new insights into the role of chemokines and their receptors. Acta Neurochir Suppl (2006) 1.08
Complement activation in the brain after experimental intracerebral hemorrhage. J Neurosurg (2000) 1.08
Systemic zinc protoporphyrin administration reduces intracerebral hemorrhage-induced brain injury. Acta Neurochir Suppl (2006) 1.08
Brain edema: a classification based on blood-brain barrier integrity. Cerebrovasc Brain Metab Rev (1989) 1.08
Ischemic brain edema and the osmotic gradient between blood and brain. J Cereb Blood Flow Metab (1988) 1.06
Attenuation of ischemic brain edema and cerebrovascular injury after ischemic preconditioning in the rat. J Cereb Blood Flow Metab (2001) 1.06
Understanding non-disclosure of deferrable risk: a study of blood donors with a history of intravenous drug use. Transfus Med (2009) 1.06
Recurrence of acoustic neuroma after incomplete resection. Am J Otol (2000) 1.05
Iron-induced oxidative brain injury after experimental intracerebral hemorrhage. Acta Neurochir Suppl (2006) 1.05
Brain death, apneic diffusion oxygenation, and organ transplantation. J Trauma (1978) 1.05
Hearing preservation following suboccipital removal of acoustic neuromas. Laryngoscope (1990) 1.04
Mechanisms of 5-aminolevulinic acid uptake at the choroid plexus. J Neurochem (2000) 1.04
Human cortex development: estimates of neuronal numbers indicate major loss late during gestation. J Neuropathol Exp Neurol (1996) 1.03
Deferoxamine reduces CSF free iron levels following intracerebral hemorrhage. Acta Neurochir Suppl (2006) 1.03
Barbiturate protection from cerebral infarction in primates. Stroke (1975) 1.03
Effects of intraventricular infusion of vascular endothelial growth factor on cerebral blood flow, edema, and infarct volume. Acta Neurochir (Wien) (2003) 1.02
Microglial activation and brain injury after intracerebral hemorrhage. Acta Neurochir Suppl (2008) 1.02
Hyperglycemia and the vascular effects of cerebral ischemia. Stroke (1997) 1.01
Posttraumatic progressive myelopathy. Clinical and radiologic correlation employing MR imaging, delayed CT metrizamide myelography, and intraoperative sonography. Radiology (1985) 1.00
Spontaneous intracerebral hemorrhage in humans: hematoma enlargement, clot lysis, and brain edema. Acta Neurochir Suppl (2006) 1.00
Leukotrienes increase blood-brain barrier permeability following intraparenchymal injections in rats. Ann Neurol (1985) 1.00
Blood-brain barrier permeability and brain concentration of sodium, potassium, and chloride during focal ischemia. J Cereb Blood Flow Metab (1994) 0.99
Transport of 5-aminolevulinic acid between blood and brain. Brain Res (2003) 0.98
Hydrocephalus in a rat model of intraventricular hemorrhage. Acta Neurochir Suppl (2006) 0.98
Brain edema after intracerebral hemorrhage: the effects of systemic complement depletion. Acta Neurochir Suppl (2002) 0.98
Experimental cervical myelopathy. Effects of ischemia and compression of the canine cervical spinal cord. J Neurosurg (1975) 0.98
The Wyburn-Mason syndrome. Concomitant chiasmal and fundus vascular malformations. J Clin Neuroophthalmol (1983) 0.93
Hyperglycemia induces progressive changes in the cerebral microvasculature and blood-brain barrier transport during focal cerebral ischemia. Acta Neurochir Suppl (1998) 0.92
The role of the coagulation cascade in brain edema formation after intracerebral hemorrhage. Acta Neurochir (Wien) (1996) 0.92
Barbiturate protection in acute focal cerebral ischemia. Stroke (1974) 0.92
Cerebral hemangioblastoma occurring in a patient with von Hippel-Lindau disease. Case report. J Neurosurg (1968) 0.91
Angiographic demonstration of hemorrhage into the fourth ventricle. Case report. J Neurosurg (1969) 0.90
Urinary retention following routine neurosurgical spine procedures. Surg Neurol (2001) 0.89
Activation of p44/42 mitogen activated protein kinases in thrombin-induced brain tolerance. Brain Res (2001) 0.89